Search Results - "Arzneimittel-Forschung"
-
1
Bioequivalence of two lansoprazole delayed release capsules 30 mg in healthy male volunteers under fasting, fed and fasting-applesauce conditions: a partial replicate crossover study design to estimate the pharmacokinetics of highly variable drugs
Published in Drug research (Stuttgart) (01-11-2013)“…An open-label, 2-treatment, 3-sequence, 3-period, single-dose, partial replicate crossover studies under fasting (n=48), fed (n=60) and fasting-applesauce…”
Get more information
Journal Article -
2
The Preventive Oral Supplementation of a Selenium Nanoparticle-enriched Probiotic Increases the Immune Response and Lifespan of 4T1 Breast Cancer Bearing Mice
Published in Arzneimittel-Forschung (01-11-2012)“…The immunomodulatory effects of lactic acid bacteria have been demonstrated previously. In this study, a Lactobacillus plantarum strain was selected and…”
Get full text
Journal Article -
3
Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
Published in Drug research (01-08-2013)“…The previous study reported CJY, an isoflavone, can reverse P-glycoprotein (P-gp)-mediated multidrug-resistance (MDR) in doxorubicin-resistant human…”
Get more information
Journal Article -
4
Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure
Published in Arzneimittel-Forschung (2008)“…Drug resistance is the major reason for failure in cancer chemotherapy. Resistance may be either pre-existent (intrinsic resistance), or induced by drugs…”
Get full text
Journal Article -
5
Intrinsic and Acquired Drug Resistance in Malignant Tumors
Published in Arzneimittel-Forschung (2008)Get full text
Journal Article -
6
Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features : A randomised, placebo-controlled, double-blind clinical trial
Published in Arzneimittel-Forschung (2007)“…In previous trials of the Ginkgo biloba special extract EGb 761 improvements in cognitive functioning and behavioural symptoms were found in patients with…”
Get full text
Journal Article -
7
Development of a Subcutaneous Formulation for Trastuzumab: Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen
Published in Arzneimittel-Forschung (01-09-2012)“…A subcutaneous (SC) formulation has been developed for the humanized monoclonal antibody (mAb) trastuzumab as an alternative to established intravenous (IV)…”
Get full text
Journal Article -
8
Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage Forms
Published in Arzneimittel-Forschung (01-12-2012)“…To better understand the pharmacokinetics and potential advantages of a levothyroxine oral solution vs. tablets and soft gel capsules.4 randomized,…”
Get full text
Journal Article -
9
Anti-nociceptive and Anti-inflammatory Effects of Cyanocobalamin (Vitamin B12) Against Acute and Chronic Pain and Inflammation in Mice
Published in Arzneimittel-Forschung (01-07-2012)“…In this study, the anti-nociceptive and anti-inflammatory effects of cyanocobalamin (Vit B12) against acute and chronic pain and inflammation were evaluated in…”
Get full text
Journal Article -
10
Paracetamol (acetaminophen) - a popular and widely used nonopioid analgesic
Published in Arzneimittel-Forschung (01-08-2012)“…For several decades paracetamol has proven its clinical efficacy and safety in the treatment of various acute and chronic pain states. Whereas its…”
Get full text
Journal Article -
11
Design, Synthesis and Antihistaminic (H1)Activity of Some Condensed 2-(Substituted)arylaminoethyl-pyrimidin-4(3H)-ones
Published in Arzneimittel-Forschung (26-12-2011)Get full text
Journal Article -
12
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents : A single-blind clinical investigation
Published in Arzneimittel-Forschung (2007)“…Berberine (BERB) and a combination (COMB) of berberine (CAS 2086-83-1) with policosanol (CAS 557-61-9), red yeast extract (containing monacolin, CAS 557-61-9),…”
Get full text
Journal Article -
13
The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review
Published in Arzneimittel-Forschung (01-01-2010)“…Iron-deficiency anaemia (IDA) is a major health problem worldwide, but responds well to iron supplementation. New approaches are leading to more effective…”
Get full text
Journal Article -
14
The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose
Published in Arzneimittel-Forschung (01-01-2010)“…An ideal preparation for intravenous iron replacement therapy should balance effectiveness and safety. Compounds that release iron rapidly tend to cause…”
Get full text
Journal Article -
15
Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model
Published in Arzneimittel-Forschung (01-01-2011)“…Intravenous (i.v.) iron is associated with a risk of oxidative stress. The effects of ferumoxytol, a recently approved i.v. iron preparation, were compared…”
Get full text
Journal Article -
16
Male Reproductive Toxicity and Toxicokinetics of Triptolide in Rats
Published in Arzneimittel-Forschung (01-01-2008)“…As the unique quality control standard of Tabellae Glucosidorum Tripterygii Totorum, triptolide (CAS 38748-32-2) has a narrow therapeutic window. A significant…”
Get full text
Journal Article -
17
Protective Effect of Puerarin on β-Amyloid-Induced Neurotoxicity in Rat Hippocampal Neurons
Published in Arzneimittel-Forschung (01-04-2012)“…Puerarin (CAS Number 3681-99-0), a major isoflavone glycoside purified from Pueraria lobata, was reported to possess antioxidative and estrogen-like biological…”
Get full text
Journal Article -
18
Dapson in Heterocyclic Chemistry Part VI: Synthesis and Molecular Docking of Some Novel Sulfonebiscompounds of Expected Anticancer Activity
Published in Arzneimittel-Forschung (01-11-2012)“…To discover new bioactive lead compounds for medicinal purposes, herein, sulfone biscompounds bearing dihydrothiazoles (3-9, 14, 15), acrylamide (11),…”
Get full text
Journal Article -
19
Antioxidative and Lipid Lowering Effects of 7,8-Dihydroxy-3-(4-methylphenyl) Coumarin in Hyperlipidemic Rats
Published in Arzneimittel-Forschung (01-01-2009)“…In this study, 7,8-dihydroxy-3-(4-methylphenyl) coumarin (DHMPC), a new coumarin derivative, was tested for the first time to determine whether it had any…”
Get full text
Journal Article -
20
Synthesis and anticonvulsant activity of new kojic acid derivatives
Published in Arzneimittel-Forschung (01-01-2010)“…A series of new 3-hydroxy-6-hydroxymethyl-2-substituted 4H-pyran-4-one derivatives were synthesized as potential anticonvulsant compounds. Mannich compounds…”
Get full text
Journal Article